Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Esther Hulleman

Principal Investigator

--

Phone 088 97 252 14

--

  • Gemcitabine therapeutically disrupts essential SIRT1-mediated p53 repression in atypical teratoid/rhabdoid tumors

    • sep. 2024
    • Dennis S, Metselaar, et al
    • Cell Reports Medicine
  • The heterogeneous sensitivity of pediatric brain tumors to different oncolytic viruses is predicted by unique gene expression profiles

    • apr. 2024
    • Konstantinos, Vazaios, et al
    • Molecular therapy. Oncology
  • A road map for the treatment of pediatric diffuse midline glioma

    • nov. 2023
    • , et al
    • Cancer Cell
  • Microglia in pediatric brain tumors

    • nov. 2023
    • Aimée, du Chatinier, et al
    • Cell Reports Medicine
  • Tocilizumab for the fifth progression of cystic childhood craniopharyngioma-a case report

    • okt. 2023
    • Evelien, de Vos-Kerkhof, et al
    • Frontiers in endocrinology
View all publications